DiMaio, VJM, DiMaio, D. Forensic Pathology, 2nd edn. CRC Press, Boca Raton, FL, 2001.
Matthews, AW, Barritt, DW, Keen, GE, et al. Preoperative mortality in aortic stenosis. Br Heart J
1974; 36: 101–103.
Chizner, MA, Pearle, DL, deLeon, AC Jr. The natural history of aortic stenosis in adults. Am Heart J
1980; 99: 419–424.
Ross, J Jr, Braunwald, E. Aortic stenosis. Circulation
1968; 38 (Suppl.): V61–V67.
Kelly, TA, Rothbart, RM, Cooper, CM, et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol
1988; 61: 123–130.
Pellikka, PA, Nishimura, RA, Bailey, KR, et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol
1990; 15: 1012–1017.
Makkar, RR, Fromm, BS, Steinman, RT, Meissner, MD, Lehmann, MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA
1993; 270: 2590–2597.
Bednar, MM, Harrigan, EP, Ruskin, JN. Torsades de pointes associated with non-antiarrhythmic drugs and observations on gender and QTc. Am J Cardiol
2002; 89: 1316–1319.
Antzelevitch, C, Shimizu, W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol
2002; 17: 43–51.
Heist, EK, Ruskin, JN. Drug-induced arrhytmia. Circulation
2010; 122: 1426–1435.
Roden, DM. Drug-induced prolongation of the QT interval. N Engl J Med
2004; 350: 1013–1022.
Kay, GN, Plumb, VJ, Arciniegas, JG, Henthorn, RW, Waldo, AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol
1983; 2: 806–817.
Bednar, MM, Edmund, P, Harrigan, EP, Anziano, RJ, Camm, AJ, Ruskin, JN. The QT interval. Prog Cardiovasc Dis
2001; 43: 1–45.
Roden, DM, Woosley, RL, Primm, RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J
1986; 111: 1088–1093.
Capps, SB, Elkins, RC, Fronk, DM. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg
2000; 119: 975–982.
Haycock, GB, Schwartz, GJ, Wisotsky, DH. Geometric method for measuring body surface area: a height weight formula validated in infants, children and adults. J Pediatr
1978; 93: 62–66.
Basso, C, Burke, M, Fornes, P, et al. Association for European Cardiovascular Pathology Guidelines for autopsy investigation of sudden cardiac death. Pathologica
2010; 102: 391–404.
Basso, C, Carturan, E, Pilichou, K, Rizzo, S, Corrado, D, Thiene, G. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol
2010; 19: 321–325.
Molina, DK, DiMaio, VJM. Normal organ weights in men, Part I – the heart. Am J Forensic Med Pathol
2012; 33: 362–367.
Fagard, R. Athlete’s heart. Heart
2003; 89: 1455–1461.
Fananapazir, L, Tracy, CM, Leon, MB, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy consecutive analysis of 155 patients. Circulation
1989; 80: 1259–1268.
Anderson, KP, Stinson, EB, Derby, GC, et al. Vulnerability of patients with obstructive hypertrophic cardiomyopathy to ventricular arrhythmia induction in the operating room: analysis of 17 patients. Am J Cardiol
1983; 51: 811–816.
Von Olshausen, K, Witt, T, Pop, T, et al. Sudden cardiac death while wearing Holter monitor. Am J Cardiol
1991; 67: 381–386.
Nikolic, G, Haffty, BG, Bishop, RL, et al. Sudden death in aortic stenosis monitored by ear densitographic pulse and ECG. Am Heart J
1982; 104: 311–312.
Schulz, M, Iwersen-Bergmann, S, Andersen, H, Schmoldt, A. Therapeutic and toxic blood concentrations or nearly 1000 drugs and other xenobiotics. Crit Care
2012; 16: R136, [Epub ahead of print].
Pratt, CM, Hertz, RP, Ellis, BE, Crowell, SP, Louv, W, Moye, L. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol
1994; 73: 346–352.
Hanrahan, JP, Choo, PW, Carlson, W, Greineder, D, Faich, GA, Platt, R. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation: a retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann Epidemiol
1995; 5: 201–209.
Monahan, BP, Ferguson, CL, Killeavy, ES, Lloyd, BK, Troy, J, Cantilena, LR Jr. Torsades de pointes occurring in association with terfenadine use. JAMA
1990; 264: 2788–2790.
Honig, PK, Woosley, RL, Zamani, K, Conner, DP, Cantilena, LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther
1992; 52: 231–238.
Jurima-Romet, M, Crawford, K, Cyr, T, Inaba, T. Terfenadine metabolism in human liver. Drug Metab Dispos
1994; 22: 849–857.
Honig, PK, Wortham, DC, Zamani, K, Conner, DP, Mullin, J, Cantilena, LR. Terfenadine-ketoconazole interaction. JAMA
1993; 269: 1513–1518.
Mihailovic, Z, Atanasijevic, T, Popovic, V, Milosevic, MB, Sperhake, JP. Estimation of the postmortem interval by analyzing potassium in the vitreous humor: could repetitive sampling enhance accuracy?
Am J Forensic Med Pathol
2012; 33: 400–403.
Palmiere, C, Mangin, P. Postmortem chemistry update part I. Int J Legal Med
2012; 126: 187–198.
Higgins, JP, Tuttle, TD, Higgins, CL. Energy beverages: content and safety. Mayo Clin Proc
2010; 85: 1033–1041.
Gunja, N, Brown, JA. Energy drinks: health risks and toxicity. Med J Aust
2012; 196: 46–49.
McCusker, RR, Goldberger, BA, Cone, EJ. Caffeine content of energy drinks, carbonated sodas, and other beverages. J Anal Toxicol
2006; 30: 112–114.
Klatsky, AL, Hasan, AS, Armstrong, MA, Udaltsova, N, Morton, C. Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J
2011; 15: 19–25.
Denison, H, Jern, S, Jagenburg, R, Wendestam, C, Wallerstedt, S. Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J
1994; 72: 554–560.
Maki, T, Toivonen, L, Koskinen, P, Naveri, H, Harkonen, M, Leinonen, H. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol induced atrial fibrillation. Am J Cardiol
1998; 82: 317–322.
Preedy, VR, Siddiq, T, Why, H, Richardson, PJ. The deleterious effects of alcohol on the heart: involvement of protein turnover. Alcohol Alcohol
1994; 29: 141–147.
Marcus, GM, Smith, LM, Whiteman, D, et al. Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol
2008; 31: 266–272.
Steinbigler, P, Haberl, R, Konig, B, Steinbeck, G. P-wave signal averaging identifies patients prone to alcohol-induced paroxysmal atrial fibrillation. Am J Cardiol
2003; 91: 491–494.
Habuchi, Y, Furukawa, T, Tanaka, H, Lu, LL, Morikawa, J, Yoshimura, M. Ethanol inhibition of Ca2+ and Na+ currents in the guinea-pig heart. Eur J Pharmacol
1995; 292: 143–149.
Buckingham, TA, Kennedy, HL, Goenjian, AK, et al. Cardiac arrhythmias in a population admitted to an acute alcoholic detoxification center. Am Heart J
1985; 110: 961–965.
Liu, J, Wang, Y, Shan, Z, Guo, H. Influence of acute stress on cardiac electrophysiological stability in male goats. Acta Cardiol
2012; 67: 325–330.
Itabashi, H, et al. Forensic Neuropathology: A Practical Review of the Fundamentals, 1st edn. Elsevier, London, 2007.
Hirvonen, J, Huttunen, P. Postmortem changes in serum noradrenaline and adrenaline concentrations in rabbit and human cadavers. Int J Legal Med
1996; 109: 143–146.
Wilke, N, Janssen, H, Fahrenhorst, C, et al. Post-mortem determination of concentrations of stress hormones in various body fluids – is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time?
Int J Legal Med
2007; 121: 385–394.